Roueen Rafeyan, MD

Department of Psychiatry, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

JCP
Patient Functioning and Life Engagement: Treatment Goals in MDD
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Major Depressive Disorder
JCP
Patient Functioning and Life Engagement: Treatment Goals in Schizophrenia
JCP
Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
JCP
Patient Functioning and Life Engagement: Unmet Needs in MDD and Schizophrenia
JCP
Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics
JCP
Switching Versus Augmentation in Patients With Inadequate Antidepressant Response
JCP
Residual Symptoms Seen in Patients With Inadequate Antidepressant Response
JCP
Benefits of Implementing Measurement-Based Care in Clinical Practice
JCP
JCP
Overcoming Challenges to Treat Inadequate Response in MDD